PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model

Horng Tay Tzeng, Huei-Fang Tsai, Hsiu Jung Liao, Yi Jiun Lin, Lieping Chen, Pei Jer Chen, Ping Ning Hsu

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Persistent hepatitis B viral (HBV) infection results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Recent studies in animal models of viral infection indicate that the interaction between the inhibitory receptor, programmed death (PD)-1, on lymphocytes and its ligand (PD-L1) play a critical role in T-cell exhaustion by inducing T-cell inactivation. High PD-1 expression levels by peripheral T-lymphocytes and the possibility of improving T-cell function by blocking PD-1-mediated signaling confirm the importance of this inhibitory pathway in inducing T-cell exhaustion. We studied T-cell exhaustion and the effects of PD-1 and PD-L1 blockade on intrahepatic infiltrating T-cells in our recently developed mouse model of HBV persistence. In this mouse animal model, we demonstrated that there were increased intrahepatic PD-1-expressing CD8+ and CD4+ T cells in mice with HBV persistence, but PD-1 upregulation was resolved in mice which had cleared HBV. The Intrahepatic CD8+ T-cells expressed higher levels of PD-1 and lower levels of CD127 in mice with HBV persistence. Blockade of PD-1/PD-L1 interactions increased HBcAg-specific interferon (IFN)-γ production in intrahepatic T lymphocytes. Furthermore, blocking the interaction of PD-1 with PD-L1 by an anti-PD-1 monoclonal antibody (mAb) reversed the exhausted phenotype in intrahepatic T lymphocytes and viral persistence to clearance of HBV in vivo. Our results indicated that PD-1 blockage reverses immune dysfunction and viral persistence of HBV infection in a mouse animal model, suggesting that the anti-PD-1 mAb might be a good therapeutic candidate for chronic HBV infection.

Original languageEnglish
Article numbere39179
JournalPLoS One
Volume7
Issue number6
DOIs
Publication statusPublished - Jun 22 2012

Fingerprint

T-cells
hepatitis B
Hepatitis B
Animals
Animal Models
animal models
death
T-lymphocytes
T-Lymphocytes
Virus Diseases
Monoclonal Antibodies
Hepatitis B Core Antigens
infection
Lymphocytes
monoclonal antibodies
mice
Liver
chronic hepatitis B
Interferons
chronic hepatitis

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Tzeng, H. T., Tsai, H-F., Liao, H. J., Lin, Y. J., Chen, L., Chen, P. J., & Hsu, P. N. (2012). PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model. PLoS One, 7(6), [e39179]. https://doi.org/10.1371/journal.pone.0039179

PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model. / Tzeng, Horng Tay; Tsai, Huei-Fang; Liao, Hsiu Jung; Lin, Yi Jiun; Chen, Lieping; Chen, Pei Jer; Hsu, Ping Ning.

In: PLoS One, Vol. 7, No. 6, e39179, 22.06.2012.

Research output: Contribution to journalArticle

Tzeng, HT, Tsai, H-F, Liao, HJ, Lin, YJ, Chen, L, Chen, PJ & Hsu, PN 2012, 'PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model', PLoS One, vol. 7, no. 6, e39179. https://doi.org/10.1371/journal.pone.0039179
Tzeng, Horng Tay ; Tsai, Huei-Fang ; Liao, Hsiu Jung ; Lin, Yi Jiun ; Chen, Lieping ; Chen, Pei Jer ; Hsu, Ping Ning. / PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model. In: PLoS One. 2012 ; Vol. 7, No. 6.
@article{b118d7eeae6445f894bbb89c9a1a96cb,
title = "PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model",
abstract = "Persistent hepatitis B viral (HBV) infection results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Recent studies in animal models of viral infection indicate that the interaction between the inhibitory receptor, programmed death (PD)-1, on lymphocytes and its ligand (PD-L1) play a critical role in T-cell exhaustion by inducing T-cell inactivation. High PD-1 expression levels by peripheral T-lymphocytes and the possibility of improving T-cell function by blocking PD-1-mediated signaling confirm the importance of this inhibitory pathway in inducing T-cell exhaustion. We studied T-cell exhaustion and the effects of PD-1 and PD-L1 blockade on intrahepatic infiltrating T-cells in our recently developed mouse model of HBV persistence. In this mouse animal model, we demonstrated that there were increased intrahepatic PD-1-expressing CD8+ and CD4+ T cells in mice with HBV persistence, but PD-1 upregulation was resolved in mice which had cleared HBV. The Intrahepatic CD8+ T-cells expressed higher levels of PD-1 and lower levels of CD127 in mice with HBV persistence. Blockade of PD-1/PD-L1 interactions increased HBcAg-specific interferon (IFN)-γ production in intrahepatic T lymphocytes. Furthermore, blocking the interaction of PD-1 with PD-L1 by an anti-PD-1 monoclonal antibody (mAb) reversed the exhausted phenotype in intrahepatic T lymphocytes and viral persistence to clearance of HBV in vivo. Our results indicated that PD-1 blockage reverses immune dysfunction and viral persistence of HBV infection in a mouse animal model, suggesting that the anti-PD-1 mAb might be a good therapeutic candidate for chronic HBV infection.",
author = "Tzeng, {Horng Tay} and Huei-Fang Tsai and Liao, {Hsiu Jung} and Lin, {Yi Jiun} and Lieping Chen and Chen, {Pei Jer} and Hsu, {Ping Ning}",
year = "2012",
month = "6",
day = "22",
doi = "10.1371/journal.pone.0039179",
language = "English",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model

AU - Tzeng, Horng Tay

AU - Tsai, Huei-Fang

AU - Liao, Hsiu Jung

AU - Lin, Yi Jiun

AU - Chen, Lieping

AU - Chen, Pei Jer

AU - Hsu, Ping Ning

PY - 2012/6/22

Y1 - 2012/6/22

N2 - Persistent hepatitis B viral (HBV) infection results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Recent studies in animal models of viral infection indicate that the interaction between the inhibitory receptor, programmed death (PD)-1, on lymphocytes and its ligand (PD-L1) play a critical role in T-cell exhaustion by inducing T-cell inactivation. High PD-1 expression levels by peripheral T-lymphocytes and the possibility of improving T-cell function by blocking PD-1-mediated signaling confirm the importance of this inhibitory pathway in inducing T-cell exhaustion. We studied T-cell exhaustion and the effects of PD-1 and PD-L1 blockade on intrahepatic infiltrating T-cells in our recently developed mouse model of HBV persistence. In this mouse animal model, we demonstrated that there were increased intrahepatic PD-1-expressing CD8+ and CD4+ T cells in mice with HBV persistence, but PD-1 upregulation was resolved in mice which had cleared HBV. The Intrahepatic CD8+ T-cells expressed higher levels of PD-1 and lower levels of CD127 in mice with HBV persistence. Blockade of PD-1/PD-L1 interactions increased HBcAg-specific interferon (IFN)-γ production in intrahepatic T lymphocytes. Furthermore, blocking the interaction of PD-1 with PD-L1 by an anti-PD-1 monoclonal antibody (mAb) reversed the exhausted phenotype in intrahepatic T lymphocytes and viral persistence to clearance of HBV in vivo. Our results indicated that PD-1 blockage reverses immune dysfunction and viral persistence of HBV infection in a mouse animal model, suggesting that the anti-PD-1 mAb might be a good therapeutic candidate for chronic HBV infection.

AB - Persistent hepatitis B viral (HBV) infection results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Recent studies in animal models of viral infection indicate that the interaction between the inhibitory receptor, programmed death (PD)-1, on lymphocytes and its ligand (PD-L1) play a critical role in T-cell exhaustion by inducing T-cell inactivation. High PD-1 expression levels by peripheral T-lymphocytes and the possibility of improving T-cell function by blocking PD-1-mediated signaling confirm the importance of this inhibitory pathway in inducing T-cell exhaustion. We studied T-cell exhaustion and the effects of PD-1 and PD-L1 blockade on intrahepatic infiltrating T-cells in our recently developed mouse model of HBV persistence. In this mouse animal model, we demonstrated that there were increased intrahepatic PD-1-expressing CD8+ and CD4+ T cells in mice with HBV persistence, but PD-1 upregulation was resolved in mice which had cleared HBV. The Intrahepatic CD8+ T-cells expressed higher levels of PD-1 and lower levels of CD127 in mice with HBV persistence. Blockade of PD-1/PD-L1 interactions increased HBcAg-specific interferon (IFN)-γ production in intrahepatic T lymphocytes. Furthermore, blocking the interaction of PD-1 with PD-L1 by an anti-PD-1 monoclonal antibody (mAb) reversed the exhausted phenotype in intrahepatic T lymphocytes and viral persistence to clearance of HBV in vivo. Our results indicated that PD-1 blockage reverses immune dysfunction and viral persistence of HBV infection in a mouse animal model, suggesting that the anti-PD-1 mAb might be a good therapeutic candidate for chronic HBV infection.

UR - http://www.scopus.com/inward/record.url?scp=84862653383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862653383&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0039179

DO - 10.1371/journal.pone.0039179

M3 - Article

C2 - 22761734

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - e39179

ER -